Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | MMP1 | P03956 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | MMP3 | P08254 | 1/20 | 0.47 |
| ▸ | MMP8 | P22894 | 1/20 | 0.47 |
| ▸ | KDM5A | P29375 | 9/20 | 0.46 |
| ▸ | KDM4C | Q9H3R0 | 9/20 | 0.46 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.43 |
| ▸ | KDM4A | O75164 | 2/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.42 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
| ▸ | KDM5C | P41229 | 1/20 | 0.41 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1128973 | 0.91 | KDM5A (0.49) | CA12CA1CA9KDM5AKDM4C | |
| SCHEMBL283713 | 0.88 | CA12 (0.56) | CA12CA1CA9MMP1MMP2 | |
| SCHEMBL15512222 | 0.83 | HAO1 (0.47) | CA12CA1CA9MMP1MMP2 | |
| SCHEMBL2417403 | 0.82 | CA12 (0.50) | CA12CA1CA9MMP1MMP2 | |
| SCHEMBL3625206 | 0.81 | CA12 (0.48) | CA12CA1CA9MMP1MMP2 | |
| SCHEMBL15512059 | 0.81 | KMT2A (0.50) | KDM5AKDM4CPHF8AKR1B1ALDH1A1 | |
| SCHEMBL11192785 | 0.80 | KDM4C (0.49) | KDM5AKDM4CPHF8KDM4AAKR1B1 | |
| SCHEMBL12323564 | 0.80 | CA12 (0.48) | CA12CA1CA9MMP1MMP2 | |
| SCHEMBL15016405 | 0.80 | CA12 (0.48) | CA12CA1CA9MMP1MMP2 | |
| SCHEMBL10339549 | 0.80 | ALDH1A1 (0.52) | CA12CA1CA9MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873468-B2 | Polymers for the treatment of surfaces | HENKEL AG & CO. KGAA (DE) | 2024-01-16 | — | — | US | disclosed |
| US-20110070657-A1 | DETECTING IONS AND MEASURING ION CONCENTRATIONS | THE GENERAL HOSPITAL CORPORATION (US) | 2011-03-24 | — | — | US | disclosed |
| US-20110070657-A1 | DETECTING IONS AND MEASURING ION CONCENTRATIONS | THE GENERAL HOSPITAL CORPORATION (US) | 2011-03-24 | — | — | US | disclosed |
| EP-1996602-B1 | NOVEL LACTOSAMINE DERIVATIVES | GLYCOM APS (DK) | 2011-02-16 | — | — | EP | disclosed |
| WO-2009026251-A1 | DETECTING IONS AND MEASURING ION CONCENTRATIONS | THE GENERAL HOSPITAL CORPORATION (US) | 2009-02-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110070657-A1 | DETECTING IONS AND MEASURING ION CONCENTRATIONS | CA2, SLC30A5, CA3 | CA12 68/4885CA1 36/4885CA9 188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.